
The Potential for CRISPR Gene Editing in HIV

NYU Prof Harnesses CRISPR to End Muscular Dystrophy

The Ups and Downs of Biosimilar Development

Biosimilars: Providing More Treatment Options

What’s New in U.S. Biosimilar-Land?

Advances in Immunotherapy for Cancer

Immunotherapy: The Next Frontier for Cancer

Speed Time to Results by Incorporating Flow Cytometry into the CRISPR‑Cas9 Gene Editing Workflow

The Importance of In Vitro Assays in the Development of Biosimilars
